Moderna said Thursday its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023. It is the first quarter that ...
Shares up nearly 5% to $54.22 in early trading Spikevax COVID vaccine sales reached $1.8 billion, beating expectations Moderna expects lower COVID vaccine sales this year compared to 2023 $10 ...
By Patrick Wingrove (Reuters) -Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its COVID-19 vaccine, even with low revenue ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the same. The Massachusetts-based company said that third-quarter revenue ...
The NHS have warned people to protect themselves from a 'tripledemic' of viruses this winter. Covid, strep and a sore throat can have similar symptoms. Phil Day, Superintendent Pharmacist at ...
MODERNA reported a surprise third-quarter profit on Thursday (Nov 7), driven by cost cutting and higher-than-expected sales of its Covid-19 vaccine, even with low revenue from its new respiratory ...
Instead of managing symptoms like a sore throat, they address the underlying cause to prevent reactions to an allergen. Healthcare providers give allergy shots in their offices. Allergy shots are a ...
Despite disappointing sales of its respiratory syncytial virus shot, Moderna on Thursday beat consensus revenue estimates in the third quarter, driven primarily by better-than-expected COVID-19 ...